Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers
USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening
Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival
Immunotherapy Demonstrates Disease Control in Phase II Study
Finasteride Does Not Affect Quality of Life, Says Study
Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years
Study: Lack of Sleep Linked With Agressive Breast Cancers
HPV Can Affect Response To Radiation Therapies
Researchers Find 16 Gene Variants Linked to Colorectal Cancer Using CRCgene Database
NCI-Approved CTEP Trials For the Month of September
FDA Approves Imaging Agent For Recurrent Prostate Cancer
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- CBER Director Vinay Prasad dared to “say no to drugs”
- Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
